AYTU Stock Summary and Trading Ideas (Aytu Biopharma | NASDAQ:AYTU)

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Aytu Biopharma trades on the NASDAQ stock market under the symbol AYTU.

As of April 25, 2024, AYTU stock price climbed to $2.81 with 1,348 million shares trading.

AYTU has a beta of 1.15, meaning it tends to be more sensitive to market movements. AYTU has a correlation of 0.02 to the broad based SPY ETF.

AYTU has a market cap of $15.64 million. This is considered a Sub-Micro Cap stock.

Last quarter Aytu Biopharma reported $23 million in Revenue and -$.04 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.21.

In the last 3 years, AYTU stock traded as high as $144.00 and as low as $1.38.

The top ETF exchange traded funds that AYTU belongs to (by Net Assets): VXF, DFAT, DFAC.

AYTU has underperformed the market in the last year with a price return of +4.5% while the SPY ETF gained +23.1%. AYTU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.6% and -12.6%, respectively, while the SPY returned +3.6% and -2.5%, respectively.

AYTU support price is $2.66 and resistance is $2.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AYTU stock will trade within this expected range on the day.